Ingrid Oakley-Girvan, Ph.D., M.P.H.
Research Scientist, Cancer Prevention Institute of California
Consulting Assistant Professor, Division of Epidemiology, Dept. of Health Research & Policy, Stanford University School of Medicine Member, Stanford Cancer Institute
2201 Walnut Avenue, Suite 300
Fremont, California 94538-2334 E-mail: Ingrid.Oakley-Girvan@CPIC.org Phone: 510-608-5045 Fax: 510-608-5085
Research Interests:
Evaluating factors associated with racial disparities in prostate and breast cancer diagnosis, progression and survival
Evaluating genetic factors and gene/environment interactions involved in prostate and breast cancer incidence, progression and survival
Evaluating genetic factors and gene/environment interactions involved in ovarian cancer incidence and survival
Assessing quality of life and survivorship issues two or more years after diagnosis
Dr. Oakley-Girvan's research concentrates on studies of breast, ovarian and prostate cancer with an emphasis on genetic epidemiology and survivorship.
Genetic epidemiology: Identifying genes that increase susceptibility to cancer or are related to poor survival is a primary interest of Dr. Oakley-Girvan. She is part of the International Consortium for Prostate Cancer Genetics and a member in an international breast and ovarian cancer research group. Through these collaborative teams, which include a broad base of investigators from many institutions and genetic samples from many projects, Dr. Oakley-Girvan is able to focus on investigating genes that may increase a person's susceptibility to prostate, ovarian and breast cancer. In addition, she aims to identify environmental factors that reduce an individual's risk of these cancers, as well as decrease their risk of cancer recurrence and improve their chance of survival.
Survivorship: Dr. Oakley-Girvan is also actively evaluating factors associated with cancer treatment choice, quality of care, treatment outcomes and quality of life. With interests throughout the cancer survivorship continuum and an emphasis on understanding why there are disparities in survivor care, Dr. Oakley-Girvan is also focused on creating solutions. She plans to follow her current studies with education and intervention projects that will effect meaningful change, improve the life of survivors and help eliminate, or, at the very least, reduce cancer health care disparities.
Professional Memberships, Professional Activities, and Awards:
1997-2002 NCI Cancer Training Grant, Stanford University 1992 Cancer Association of New Orleans Student Research Grant 1992 Founders' Academic Scholarship, Zeta Tau Alpha Sorority 1991-1992 Deans' Grant, School of Public Health, Tulane University 1987 Order of Omega Honor Society, University of Michigan